A note on response-adaptive randomization from a Bayesian prediction viewpoint

Area of Science:

• Biostatistics
• Clinical Trial Design
• Bayesian Inference

Background:

• Adaptive randomization is crucial for efficient clinical trials.
• Existing methods may not fully optimize treatment allocation based on accumulating data and prior knowledge.
• Balancing patient benefit with inferential rigor is a key challenge.

Purpose of the Study:

• To propose a novel response-adaptive randomization rule using a Bayesian predictive distribution.
• To design a mechanism that allocates patients to treatments predicted to yield better future outcomes.
• To integrate patient benefit motivations with frequentist inferential goals.

Main Methods:

• A Bayesian approach utilizing predictive distributions to guide treatment allocation.
• A decision-theoretic framework to inform the randomization rule.
• Analysis of asymptotic properties and numerical comparisons with existing rules (e.g., Thompson rule).

Main Results:

• The proposed predictive rule demonstrates favorable properties.
• Numerical studies indicate competitive performance compared to established methods.
• The rule effectively balances patient benefit with inferential considerations.

Conclusions:

• The novel Bayesian predictive rule offers an effective strategy for adaptive randomization in clinical trials.
• This method enhances treatment allocation by considering expected future outcomes.
• The approach is robust, supported by theoretical properties and simulation studies.